Christoph Lange (C Lange)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 35

Top Topics

Polycyclic Aromatic Hydrocarbons

Acinetobacter Baumannii

Top Venues

Nature medicine

American journal of respiratory and critical care medicine

The European respiratory journal

Breathe (Sheffield, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Andreas H Diacon, Clifton Earl Barry, Alex Carlton, Ray Y Chen, Matt Davies, Veronique de Jager, Kim Fletcher, Gavin C K W Koh, Irina Kontsevaya, Jan Heyckendorf, Christoph Lange, Maja Reimann, Sophie L Penman, Rhona Scott, Gareth Maher-Edwards, Simon Tiberi, Georgios Vlasakakis, Caryn M Upton, David Barros Aguirre
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial. Nature medicine (2024)
Lennard Meiwes, Irina Kontsevaya, Dumitru Chesov, Stela Kulciţkaia, Viola Dreyer, Doris Hillemann, Qiniso Dlamini, Caroline Williams, Michael Barer, Folke Brinkmann, Renate Krüger, Stephanie Thee, Alexander W Kay, Anna Maria Mandalakas, Christoph Lange
Whispers in the wind: Face mask sampling for Mycobacterium tuberculosis detection in children with pulmonary tuberculosis. The Journal of infectious diseases (2024)
Lennard Meiwes, Irina Kontsevaya, Dumitru Chesov, Stela Kulciţkaia, Viola Dreyer, Doris Hillemann, Qiniso Dlamini, Caroline Williams, Michael Barer, Folke Brinkmann, Renate Krüger, Stephanie Thee, Alexander W Kay, Anna Maria Mandalakas, Christoph Lange
Whispers in the wind: Face mask sampling for Mycobacterium tuberculosis detection in children with pulmonary tuberculosis. The Journal of infectious diseases (2024)
Andreas H Diacon, Clifton Earl Barry, Alex Carlton, Ray Y Chen, Matt Davies, Veronique de Jager, Kim Fletcher, Gavin C K W Koh, Irina Kontsevaya, Jan Heyckendorf, Christoph Lange, Maja Reimann, Sophie L Penman, Rhona Scott, Gareth Maher-Edwards, Simon Tiberi, Georgios Vlasakakis, Caryn M Upton, David Barros Aguirre
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial. Nature medicine 30 (3) (2024)
Lennard Meiwes, Irina Kontsevaya, Dumitru Chesov, Stela Kulciţkaia, Viola Dreyer, Doris Hillemann, Qiniso Dlamini, Caroline Williams, Michael Barer, Folke Brinkmann, Renate Krüger, Stephanie Thee, Alexander W Kay, Anna Maria Mandalakas, Christoph Lange
Whispers in the wind: Face mask sampling for Mycobacterium tuberculosis detection in children with pulmonary tuberculosis. The Journal of infectious diseases (2024)
Johanna Eggeling, Barbara Kalsdorf, Dagmar Schaub, Stefanie Schierholz, Peter Hammerl, Dennis Nowak, Christoph Lange
[Everything under control?] Pneumologie (Stuttgart, Germany) (2024)
Andreas H Diacon, Clifton Earl Barry, Alex Carlton, Ray Y Chen, Matt Davies, Veronique de Jager, Kim Fletcher, Gavin C K W Koh, Irina Kontsevaya, Jan Heyckendorf, Christoph Lange, Maja Reimann, Sophie L Penman, Rhona Scott, Gareth Maher-Edwards, Simon Tiberi, Georgios Vlasakakis, Caryn M Upton, David Barros Aguirre
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial. Nature medicine 30 (3) (2024)
Johanna Eggeling, Barbara Kalsdorf, Dagmar Schaub, Stefanie Schierholz, Peter Hammerl, Dennis Nowak, Christoph Lange
[Everything under control?] Pneumologie (Stuttgart, Germany) (2024)
Andreas H Diacon, Clifton Earl Barry, Alex Carlton, Ray Y Chen, Matt Davies, Veronique de Jager, Kim Fletcher, Gavin C K W Koh, Irina Kontsevaya, Jan Heyckendorf, Christoph Lange, Maja Reimann, Sophie L Penman, Rhona Scott, Gareth Maher-Edwards, Simon Tiberi, Georgios Vlasakakis, Caryn M Upton, David Barros Aguirre
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial. Nature medicine (2024)
Andreas H Diacon, Clifton Earl Barry, Alex Carlton, Ray Y Chen, Matt Davies, Veronique de Jager, Kim Fletcher, Gavin C K W Koh, Irina Kontsevaya, Jan Heyckendorf, Christoph Lange, Maja Reimann, Sophie L Penman, Rhona Scott, Gareth Maher-Edwards, Simon Tiberi, Georgios Vlasakakis, Caryn M Upton, David Barros Aguirre
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial. Nature medicine 30 (3) (2024)
Andreas H Diacon, Clifton Earl Barry, Alex Carlton, Ray Y Chen, Matt Davies, Veronique de Jager, Kim Fletcher, Gavin C K W Koh, Irina Kontsevaya, Jan Heyckendorf, Christoph Lange, Maja Reimann, Sophie L Penman, Rhona Scott, Gareth Maher-Edwards, Simon Tiberi, Georgios Vlasakakis, Caryn M Upton, David Barros Aguirre
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial. Nature medicine 30 (3) (2024)
Andreas H Diacon, Clifton Earl Barry, Alex Carlton, Ray Y Chen, Matt Davies, Veronique de Jager, Kim Fletcher, Gavin C K W Koh, Irina Kontsevaya, Jan Heyckendorf, Christoph Lange, Maja Reimann, Sophie L Penman, Rhona Scott, Gareth Maher-Edwards, Simon Tiberi, Georgios Vlasakakis, Caryn M Upton, David Barros Aguirre
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial. Nature medicine 30 (3) (2024)
Raquel Villar-Hernández, Arash Ghodousi, Olha Konstantynovska, Raquel Duarte, Christoph Lange, Mario C Raviglione
Tuberculosis: current challenges and beyond. Breathe (Sheffield, England) 19 (1) (2023)
Francesca Saluzzo, Victor Abiola Adepoju, Raquel Duarte, Christoph Lange, Patrick Peter John Phillips
Treatment-shortening regimens for tuberculosis: updates and future priorities. Breathe (Sheffield, England) 19 (3) (2023)
Niklas Köhler, Hande Karaköse, Hans-Peter Grobbel, Doris Hillemann, Sönke Andres, Christina König, Barbara Kalsdorf, Thomas Theo Brehm, Laura Böttcher, Inna Friesen, Harald Hoffmann, Dražen Strelec, Dagmar Schaub, Charles A Peloquin, Stefan Schmiedel, Laurent A Decosterd, Eva Choong, Sebastian G Wicha, Rob E Aarnoutse, Christoph Lange, Patricia M Sánchez Carballo
A Single-Run HPLC-MS Multiplex Assay for Therapeutic Drug Monitoring of Relevant First- and Second-Line Antibiotics in the Treatment of Drug-Resistant Tuberculosis. Pharmaceutics 15 (11) (2023)
Anca Vasiliu, Antonia Morita Iswari Saktiawati, Raquel Duarte, Christoph Lange, Daniela Maria Cirillo
Implementing molecular tuberculosis diagnostic methods in limited-resource and high-burden countries. Breathe (Sheffield, England) 18 (4) (2023)
Anca Vasiliu, Antonia Morita Iswari Saktiawati, Raquel Duarte, Christoph Lange, Daniela Maria Cirillo
Implementing molecular tuberculosis diagnostic methods in limited-resource and high-burden countries. Breathe (Sheffield, England) 18 (4) (2023)
Niklas Köhler, Anca Vasiliu, Anna Maria Mandalakas, Leonardo Martinez, Christoph Lange, null null
Tuberculosis screening in migrants to the EU/EEA and UK. The European respiratory journal 62 (5) (2023)
Victor Naestholt Dahl, Giovanni Battista Migliori, Christoph Lange, Christian Morberg Wejse
War in Ukraine: an immense threat to the fight against tuberculosis. The European respiratory journal 59 (4) (2022)
Lorenzo Guglielmetti, Gunar Günther, Claude Leu, Daniela Maria Cirillo, Raquel Duarte, Alberto L Garcia-Basteiro, Delia Goletti, Mateja Jankovic Makek, Liga Kuksa, Florian P Maurer, Frédéric Méchaï, Simon Tiberi, Frank van Leth, Nicolas Veziris, Christoph Lange, null null, null null
Rifapentine access in Europe: growing concerns over key tuberculosis treatment component. The European respiratory journal 59 (5) (2022)
Christoph Lange, Clifton Earl Barry, Charles R Horsburgh
Treatments of Multidrug-Resistant Tuberculosis: Light at the End of the Tunnel. American journal of respiratory and critical care medicine 205 (10) (2022)
Dumitru Chesov, Jan Heyckendorf, Sofia Alexandru, Ana Donica, Elena Chesov, Maja Reimann, Valeriu Crudu, Victor Botnaru, Christoph Lange
Impact of bedaquiline on treatment outcomes of multidrug-resistant tuberculosis in a high-burden country. The European respiratory journal 57 (6) (2021)
Hans-Peter Grobbel, Matthias Merker, Niklas Köhler, Sönke Andres, Harald Hoffmann, Jan Heyckendorf, Maja Reimann, Ivan Barilar, Viola Dreyer, Doris Hillemann, Barbara Kalsdorf, Thomas A Kohl, Patricia Sanchez Carballo, Dagmar Schaub, Katharina Todt, Christian Utpatel, Florian P Maurer, Christoph Lange, Stefan Niemann
Design of Multidrug-Resistant Tuberculosis Treatment Regimens Based on DNA Sequencing. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 73 (7) (2021)
Barbara Kalsdorf, Christoph Lange
Tuberculous mediastinal lymphadenopathy: Reaching the target. Respirology (Carlton, Vic.) 24 (7) (2019)
Gunar Günther, Frank van Leth, Sofia Alexandru, Neus Altet, Korkut Avsar, Didi Bang, Raisa Barbuta, Graham Bothamley, Ana Ciobanu, Valeriu Crudu, Manfred Danilovits, Martin Dedicoat, Raquel Duarte, Gina Gualano, Heinke Kunst, Wiel de Lange, Vaira Leimane, Anne-Marie McLaughlin, Cecile Magis-Escurra, Inge Muylle, Veronika Polcová, Cristina Popa, Rudolf Rumetshofer, Alena Skrahina, Varvara Solodovnikova, Victor Spinu, Simon Tiberi, Piret Viiklepp, Christoph Lange, null null
Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries. American journal of respiratory and critical care medicine 198 (3) (2019)
Christoph Lange, Dumitru Chesov, Jan Heyckendorf, Chi Chiu Leung, Zarir Udwadia, Keertan Dheda
Drug-resistant tuberculosis: An update on disease burden, diagnosis and treatment. Respirology (Carlton, Vic.) 23 (7) (2018)
Ioana Diana Olaru, Christoph Lange, Alexander Indra, Liliya Meidlinger, Steliana Huhulescu, Rudolf Rumetshofer
High Rates of Treatment Success in Pulmonary Multidrug-Resistant Tuberculosis by Individually Tailored Treatment Regimens. Annals of the American Thoracic Society 13 (8) (2018)
Jan Heyckendorf, Sönke Andres, Claudio Umberto Köser, Ioana Diana Olaru, Thomas Schön, Erik Sturegård, Patrick Beckert, Viola Schleusener, Thomas A Kohl, Doris Hillemann, Danesh Moradigaravand, Julian Parkhill, Sharon J Peacock, Stefan Niemann, Christoph Lange, Matthias Merker
What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis. Antimicrobial agents and chemotherapy 62 (2) (2018)
Christoph Lange, Wael A Alghamdi, Mohammad H Alshaer, Susanna Brighenti, A H Diacon, A R DiNardo, H P Grobbel, M I Gröschel, F von Groote-Bidlingmaier, M Hauptmann, J Heyckendorf, N Köhler, T A Kohl, M Merker, S Niemann, C A Peloquin, M Reimann, U E Schaible, D Schaub, V Schleusener, T Thye, T Schön
Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis. Journal of internal medicine (2018)
Claudio Umberto Köser, Jan Heyckendorf, Sönke Andres, Ioana Diana Olaru, Thomas Schön, Erik Sturegård, Patrick Beckert, Viola Schleusener, Thomas A Kohl, Doris Hillemann, Danesh Moradigaravand, Julian Parkhill, Sharon J Peacock, Stefan Niemann, Christoph Lange, Matthias Merker
Reply to Dookie et al., "Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis". Antimicrobial agents and chemotherapy 62 (8) (2018)
Martin J Dedicoat, Gunar Günther, Valeriu Crudu, Raquel Duarte, Gina Gualano, Cecile Magis-Escurra, Rudolf Rumetshofer, Alena Skrahina, Victor Spinu, Simon Tiberi, Piret Viiklepp, Frank van Leth, Christoph Lange, null null
Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure. American journal of respiratory and critical care medicine 196 (9) (2017)
Frank van Leth, Gunar Günther, Harald Hoffmann, Christoph Lange, null null
Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria. American journal of respiratory and critical care medicine 196 (11) (2017)
Christoph Lange, Raquel Duarte, Mathilde Fréchet-Jachym, Gunar Guenther, Lorenzo Guglielmetti, Ioana Diana Olaru, Olena Oliveira, Rudolf Rumetshofer, Nicolas Veziris, Frank van Leth, null null
Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe. American journal of respiratory and critical care medicine 194 (8) (2017)
Nasstasja Wassilew, Christoph Lange
Cure Not Possible, by Definition. American journal of respiratory and critical care medicine 192 (10) (2016)
Ioana Diana Olaru, Christoph Lange, Martina Sester
Revisiting Healthcare Workers as a Risk Group for Progression toward Tuberculosis. American journal of respiratory and critical care medicine 192 (8) (2016)